Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


01.07.2019

1 Ann Thorac Surg
5 BMC Cancer
2 Br J Oral Maxillofac Surg
1 Cancer
1 Clin Cancer Res
1 Dis Esophagus
1 Head Neck
1 Histopathology
1 Int J Radiat Oncol Biol Phys
1 Laryngoscope
7 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. SEMENKOVICH TR, Subramanian M, Yan Y, Hofstetter WL, et al
    Adjuvant Therapy for Node Positive Esophageal Cancer after Induction and Surgery: A Multisite Study.
    Ann Thorac Surg. 2019 Jun 20. pii: S0003-4975(19)30864.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. YANG Y, Zhang X, Li B, Li Z, et al
    Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally
    BMC Cancer. 2019;19:608.
    PubMed     Text format     Abstract available

  3. LIU C, Xiao C, Chen J, Li X, et al
    Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    BMC Cancer. 2019;19:622.
    PubMed     Text format     Abstract available

  4. RUUSKANEN M, Leivo I, Minn H, Vahlberg T, et al
    Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:624.
    PubMed     Text format     Abstract available

  5. GUANG Y, He W, Luo Y, Zhang H, et al
    Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up.
    BMC Cancer. 2019;19:147.
    PubMed     Text format     Abstract available

  6. ZENG B, Zhang X, Zhao J, Wei Z, et al
    The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:609.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  7. MCDONALD C, Lowe D, Bekiroglu F, Schache A, et al
    Health-related quality of life in patients with T1N0 oral squamous cell carcinoma: selective neck dissection compared with wait and watch surveillance.
    Br J Oral Maxillofac Surg. 2019 Jun 20. pii: S0266-4356(19)30217.
    PubMed     Text format     Abstract available

  8. AZZOPARDI S, Lowe D, Rogers S
    Audit of the rates of re-excision for close or involved margins in the management of oral cancer.
    Br J Oral Maxillofac Surg. 2019 Jun 21. pii: S0266-4356(19)30194.
    PubMed     Text format     Abstract available


    Cancer

  9. HADDAD R, Concha-Benavente F, Blumenschein G Jr, Fayette J, et al
    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. FERRIS RL, Licitra L, Fayette J, Even C, et al
    Nivolumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.
    Clin Cancer Res. 2019 Jun 25. pii: 1078-0432.CCR-18-3944.
    PubMed     Text format     Abstract available


    Dis Esophagus

  11. ZHANG G, Li J
    Reply to the Editor: how to treat esophageal neuroendocrine carcinoma with proper stratification?
    Dis Esophagus. 2019;32.
    PubMed     Text format    


    Head Neck

  12. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    PubMed     Text format     Abstract available


    Histopathology

  13. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  14. QIAN D, Wang Y, Zhao G, Cao F, et al
    Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jun 19. pii: S0360-3016(19)30914.
    PubMed     Text format     Abstract available


    Laryngoscope

  15. HANNA J, Brauer PR, Morse E, Judson B, et al
    Is robotic surgery an option for early T-stage laryngeal cancer? Early nationwide results.
    Laryngoscope. 2019 Jun 24. doi: 10.1002/lary.28144.
    PubMed     Text format     Abstract available


    Thyroid

  16. GHAZNAVI SA, Ganly I, Shaha AR MD, English CL, et al
    Using the ATA risk stratification system to refine and individualize the AJCC 8th edition disease specific survival estimates in differentiated thyroid cancer.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0186.
    PubMed     Text format     Abstract available

  17. BRITO JP, Moon JH, Zeuren R, Kong SH, et al
    Thyroid Cancer Treatment Choice: A pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options.
    Thyroid. 2018 Jun 15. doi: 10.1089/thy.2018.0105.
    PubMed     Text format     Abstract available

  18. LLAMAS-OLIER A, Cuellar DI, Buitrago G
    Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0578.
    PubMed     Text format     Abstract available

  19. ZANELLA AB, Scheffel RS, Nava CF, Golbert L, et al
    Dynamic Risk Stratification in the Follow-up of Children and Adolescents with Differentiated Thyroid Cancer.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0075.
    PubMed     Text format     Abstract available

  20. KIM SJ, Lee SW, Jeong SY, Pak K, et al
    Diagnostic Performance of Tc-99m MIBI for Differentiation of Malignant Thyroid Nodules; A Systematic Review and Meta-analysis.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0072.
    PubMed     Text format     Abstract available

  21. TAM S, Boonsripitayanon M, Amit M, Fellman BM, et al
    Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2017.0572.
    PubMed     Text format     Abstract available

  22. RAGO T, Scutari M, Loiacono V, Tonacchera M, et al
    Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2017.0522.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: